Results 151 to 160 of about 1,572,227 (290)

Transcription Factor PFB1 Is Required for the Botrytis cinerea Effector BcSCR1-Mediated Pathogenesis. [PDF]

Mol Plant Pathol
Li X, Xie Y, Wen Q, Liu J, Kang J, Qian X, Chen X, Wang J, Yang Y.   +8 more
europepmc   +1 more source

Master Regulatory Transcription Factors in β-Aminobutyric Acid-Induced Resistance (BABA-IR): A Perspective on Phytohormone Biosynthesis and Signaling in Arabidopsis thaliana and Hordeum vulgare [PDF]

Eszter Virág, Ágnes Nagy, Beáta B. Tóth, Barbara Kutasy, József Péter Pallos, Zsuzsa M. Szigeti, Csaba Máthé, Gábor Kardos, Géza Hegedűs   +8 more
openalex   +1 more source

TEF-1 and C/EBPβ are major p38α MAPK-regulated transcription factors in proliferating cardiomyocytes [PDF]

, 2006
Concetta Ambrosino, Tomoko Iwata, Claudio Scafoglio, Massimo Mallardo, Rüdiger Klein, Ángel R. Nebreda   +5 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Editorial: Bacterial transcription factors and the cell cycle, volume II

Frontiers in Microbiology, 2023
Morigen, Monika Glinkowska, Jianping Xie, Richa Priyadarshini, Kazutoshi Kasho   +4 more
doaj   +1 more source

Biaryl Phosphate-Based Inhibitors of the Transcription Factor STAT4. [PDF]

ChemMedChem
Brovchenko N, Oelsch AM, Protzel C, Berg T.   +3 more
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

REPROGRAMMING ZFP189 TRANSCRIPTION FACTOR FUNCTION REGULATES DRUG SPECIFIC BEHAVIORAL RESPONSES AND TRANSCRIPTION

IBRO Neuroscience Reports, 2023
Joseph Picone, Peter Hamilton, Xiaohong Cui, Natalie Truby, Kijoon Kim, Gabriella Silva   +5 more
doaj   +1 more source

Benchmarking large language models for identifying transcription factor regulatory interactions. [PDF]

Bioinformatics
Noel L, Hsiao YW, He Y, Hung A, Cui X, Ray E, Moore JH, Peng PC, Huang X.   +8 more
europepmc   +1 more source

Transcription Factors [PDF]

Journal of Medical Genetics, 1996
openaire   +1 more source